A probabilistic framework for non-cancer risk assessment.

Risk assessment involves an analysis of the relationship between exposure and health related outcomes to derive an allowable exposure level or to estimate a low-dose risk. Acceptable levels of human exposure for non-cancer effects generally are derived by dividing an experimental no-observed-adverse-effect-level or a lower confidence limit benchmark dose by a product of several uncertainty factors. This paper presents a hierarchical modeling framework for a probabilistic approach to non-cancer risk assessment. The hierarchical model integrates the distributions of uncertainty factors and the distribution of the actual exposure level to construct the dose-response model for the proportion of population at risk and the dose-response model for the expected proportion of population at risk for a given exposure distribution. The proposed approach is based on the use of the BMDL (lower confidence limit on the benchmark dose) as a POD (point of departure) for risk assessment of non-cancer effects.

[1]  John F. Young,et al.  Analysis of Methylmercury Disposition in Humans Utilizing A PBPK Model and Animal Pharmacokinetic Data , 2001, Journal of toxicology and environmental health. Part A.

[2]  Jean-Pierre Gauchi,et al.  Quantitative Assessment of Exposure to the Mycotoxin Ochratoxin A in Food , 2002, Risk analysis : an official publication of the Society for Risk Analysis.

[3]  F. A. Smith,et al.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.

[4]  James J. Chen,et al.  Model Averaging Using the Kullback Information Criterion in Estimating Effective Doses for Microbial Infection and Illness , 2005, Risk analysis : an official publication of the Society for Risk Analysis.

[5]  Matthew W Wheeler,et al.  Model Uncertainty and Risk Estimation for Experimental Studies of Quantal Responses , 2005, Risk analysis : an official publication of the Society for Risk Analysis.

[6]  R L Kodell,et al.  Mathematical modeling of reproductive and developmental toxic effects for quantitative risk assessment. , 1991, Risk analysis : an official publication of the Society for Risk Analysis.

[7]  P. Watanabe,et al.  Resolution of dose-response toxicity data for chemicals requiring metabolic activation: example--vinyl chloride. , 1978, Toxicology and applied pharmacology.

[8]  Michael Dourson,et al.  A Probabilistic Framework for the Reference Dose (Probabilistic RfD) , 1998 .

[9]  Sandra J. S. Baird,et al.  Noncancer Risk Assessment: A Probabilistic Alternative to Current Practice , 1996 .

[10]  D W Gaylor,et al.  Issues in qualitative and quantitative risk analysis for developmental toxicology. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[11]  T. Starr,et al.  Quantitative cancer risk estimation for formaldehyde. , 1990, Risk analysis : an official publication of the Society for Risk Analysis.

[12]  R L Kodell,et al.  Hierarchical models for probabilistic dose-response assessment. , 2006, Regulatory toxicology and pharmacology : RTP.

[13]  Salomon Sand,et al.  The Benchmark Dose Method—Review of Available Models, and Recommendations for Application in Health Risk Assessment , 2003, Critical reviews in toxicology.

[14]  K S Crump,et al.  A new method for determining allowable daily intakes. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[15]  W. Slob,et al.  A Probabilistic Approach for Deriving Acceptable Human Intake Limits and Human Health Risks from Toxicological Studies: General Framework , 1998 .

[16]  D. Gaylor,et al.  Percentiles of the Product of Uncertainty Factors for Establishing Probabilistic Reference Doses , 2000, Risk analysis : an official publication of the Society for Risk Analysis.

[17]  Ralph L. Kodell,et al.  Quantitative Risk Assessment for Teratological Effects , 1989 .

[18]  D. Barnes,et al.  Reference dose (RfD): description and use in health risk assessments. , 1988, Regulatory toxicology and pharmacology : RTP.

[19]  Paul M Schlosser,et al.  Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses. , 2003, Risk analysis : an official publication of the Society for Risk Analysis.

[20]  J Van Ryzin,et al.  A dose-response model incorporating nonlinear kinetics. , 1987, Biometrics.